Prognostic Impact of t(4;11)(q21;q23)/KMT2A-AFF1-Positivity in 926 BCR-ABL1-Negative B-Lineage Acute Lymphoblastic Leukemia Patients Treated in Gimema Clinical Trials Since 1996

被引：0

作者：

Piciocchi, Alfonso ^{[1
]}

Messina, Monica ^{[1
]}

Elia, Loredana ^{[2
]}

Vitale, Antonella ^{[3
]}

Soddu, Stefano ^{[4
]}

Testi, Anna Maria ^{[5
]}

Chiaretti, Sabina ^{[5
]}

Mancini, Marco ^{[6
]}

Specchia, Giorgina ^{[7
]}

Spadano, Antonio ^{[8
]}

Krampera, Mauro ^{[9
]}

Cairoli, Roberto ^{[10
]}

Di Raimondo, Francesco ^{[11
]}

Ferrara, Felicetto ^{[12
,13
]}

Cimino, Giuseppe ^{[14
]}

Bassan, Renato ^{[15
]}

Fazi, Paola ^{[1
]}

Vignetti, Marco ^{[4
,16
]}

机构：

[1] GIMEMA Fdn, Rome, Italy

[2] Sapienza Univ, Div Hematol, Dept Translat & Precis Med, Rome, Italy

[3] Sapienza Univ, Div Hematol, Dept Translat & Precis Med, Rome, Italy

[4] GIMEMA Fdn, Ctr Data, Rome, Italy

[5] Sapienza Univ, Dept Translat & Precis Med, Hematol Div, Rome, Italy

[6] Sapienza Univ, Dept Translat & Precis Med, Hematol, Rome, Italy

[7] Univ Bari, Dept Emergency & Organ Transplantat, Hematol, Bari, Italy

[8] Santo Spirito Civ Hosp, Dept Hematol Transfus Med & Biotechnol, Pescara, Italy

[9] Univ Verona, Sect Hematol, Dept Med, Verona, Italy

[10] ASST Grande Osped Metropolitano Niguarda, Dept Hematol & Oncol, Milan, Italy

[11] Univ Catania, CHIRMED, Dept Gen Surg & Med Surg Specialties, Hematol Sect, Catania, Italy

[12] Cardarelli Hosp, Div Hematol, Naples, Italy

[13] Cardarelli Hosp, Stem Cell Transplantat Unit, Naples, Italy

[14] Sapienza Univ, ASL Latina, Dept Translat & Precis Med, Presidio Osped Nord,Osped Santa Maria Goretti,Hem, Latina, Italy

[15] Osped SS Giovanni & Paolo, Div Hematol, Venice, Italy

[16] Sapienza Univ, Dept Translat & Precis Med, Hematol, Rome, Italy

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-121977

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1469

引用

页数：5

共 18 条

[1] Prognostic impact of KMT2A-AFF1-positivity in 926 BCR-ABL1-negative B-lineage acute lymphoblastic leukemia patients treated in GIMEMA clinical trials since 1996
Piciocchi, Alfonso
Messina, Monica
Elia, Loredana
Vitale, Antonella
Soddu, Stefano
Testi, Anna Maria
Chiaretti, Sabina
Mancini, Marco
Albano, Francesco
Spadano, Antonio
Krampera, Mauro
Bonifacio, Massimiliano
Cairoli, Roberto
Vetro, Calogero
Colella, Florinda
Ferrara, Felicetto
Cimino, Giuseppe
Bassan, Renato
Fazi, Paola
Vignetti, Marco
AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (09) : E334 - E338
[2] Mixed- phenotype acute leukemia with t(4;11)(q21;q23) KMT2A-AFF1-rearranged
Liu, Huifei
BLOOD, 2019, 133 (11) : 1265 - 1265
[3] The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial
Marks, David I.
Moorman, Anthony V.
Chilton, Lucy
Paietta, Elisabeth
Enshaie, Amir
DeWald, Gordon
Harrison, Christine J.
Fielding, Adele K.
Foroni, Letizia
Goldstone, Anthony H.
Litzow, Mark R.
Luger, Selina M.
McMillan, Andrew K.
Racevskis, Janis
Rowe, Jacob M.
Tallman, Martin S.
Wiernik, Peter
Lazarus, Hillard M.
HAEMATOLOGICA, 2013, 98 (06) : 945 - 952
[4] Outcomes of allogeneic hematopoietic stem cell transplantation in patients with B-cell acute lymphoblastic leukemia harboring t(4;11)(q21;q23)
Aoki, Jun
Fujisawa, Shin
Mizuta, Shuichi
Ozawa, Yukiyasu
Ohashi, Kazuteru
Ota, Shuichi
Ogawa, Hiroyasu
Fukuda, Takahiro
Tanaka, Junji
Atsuta, Yoshiko
Kako, Shinichi
BONE MARROW TRANSPLANTATION, 2018, 53 : 175 - 176
[5] A rare case of therapy-related acute myeloid leukemia expressing EVI1 with t(11;19) and MLL-MLLT1 after acute B-lymphoblastic leukemia with t(4;11)(q21;q23) and MLL-AFF1
Junker, Till
Gregor, Michael
Schwaller, Jurg
Tzankov, Alexandar
Passweg, Jakob
Medinger, Michael
SWISS MEDICAL WEEKLY, 2018, 148 : 3S - 3S
[6] Lineage switch from B acute lymphoblastic leukemia to acute monocytic leukemia with persistent t(4;11)(q21;q23) and cytogenetic evolution under CD19-targeted therapy
Balducci, Estelle
Nivaggioni, Vanessa
Boudjarane, John
Bouriche, Lakhdar
Rahal, Ilhem
Bernot, Denis
Alazard, Emilie
Duployez, Nicolas
Grardel, Nathalie
Arnoux, Isabelle
Lafage-Pochitaloff, Marina
Michel, Gerard
Nadel, Bertrand
Loosveld, Marie
ANNALS OF HEMATOLOGY, 2017, 96 (09) : 1579 - 1581
[7] Lineage switch from B acute lymphoblastic leukemia to acute monocytic leukemia with persistent t(4;11)(q21;q23) and cytogenetic evolution under CD19-targeted therapy
Estelle Balducci
Vanessa Nivaggioni
John Boudjarane
Lakhdar Bouriche
Ilhem Rahal
Denis Bernot
Emilie Alazard
Nicolas Duployez
Nathalie Grardel
Isabelle Arnoux
Marina Lafage-Pochitaloff
Gérard Michel
Bertrand Nadel
Marie Loosveld
Annals of Hematology, 2017, 96 : 1579 - 1581
[8] Blinatumomab-induced lineage switch of B-ALL with t(4:11) (q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis
Haddox, C. L.
Mangaonkar, A. A.
Chen, D.
Shi, M.
He, R.
Oliveira, J. L.
Litzow, M. R.
Al-Kali, A.
Hogan, W. J.
Elliott, M. A.
BLOOD CANCER JOURNAL, 2017, 7 : e607 - e607
[9] Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis
C L Haddox
A A Mangaonkar
D Chen
M Shi
R He
J L Oliveira
M R Litzow
A Al-Kali
W J Hogan
M A Elliott
Blood Cancer Journal, 2017, 7 : e607 - e607
[10] Allogeneic hematopoietic stem cell transplantation for adult patients with t(4;11)(q21;q23) KMT2A/AFF1 B-cell precursor acute lymphoblastic leukemia in first complete remission: impact of pretransplant measurable residual disease (MRD) status. An analysis from the Acute Leukemia Working Party of the EBMT
Jordi Esteve
Sebastian Giebel
Myriam Labopin
Tomasz Czerw
Depei Wu
Liisa Volin
Gerard Socié
Ibrahim Yakoub-Agha
Johan Maertens
Jan J. Cornelissen
Arnaud Pigneux
Avichai Shimoni
Rainer Schwerdtfeger
Hélène Labussière-Wallet
Nigel Russell
Anton Schattenberg
Patrice Chevallier
Vladimir Koza
Robin Foà
Christoph Schmid
Zinaida Peric
Mohamad Mohty
Arnon Nagler
Leukemia, 2021, 35 : 2232 - 2242

← 1 2 →